Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the SURMOUNT-1 trial published in the New England Journal of Medicine , once-weekly Tirzepatide produced dose-dependent reductions in body weight over 72 weeks in adults with obesity or overweight, with the highest-dose arm showing some of the strongest weight-loss outcomes reported at the time for an incretin-based therapy
Its known more commonly by brand names Mounjaro and Zepbound
This product is available in Pineapple Mango and Mixed Berry
Sun maps a dose-escalation schedule
The study concluded that GHRP-6 is a potent synthetic GH secretagogue that stimulates GH release from the pituitary gland and will be studied further in clinical settings about GH deficiency, abdominal obesity, and cachexia in subjects in the future
